Arima Genomics Appoints Genomics Industry Veteran Tom Willis as Chief Executive Officer and Closes $22 Million Series C Financing
Illumina Ventures leads round to accelerate Arima’s clinical expansion.
News
listing-news
Latest News
Spotlight on Carey-Ann Burnham, PhD – CEO Pattern Bioscience May 2025
Spotlight on Carey-Ann Burnham, PhD – CEO Pattern Bioscience
Illumina Ventures’ Diagnostics Year in Review 2024 Report
Latest industry segment report offering key insights into the current trends, challenges and opportunities facing the diagnostics industry.
Attovia Therapeutics Announces $90 Million Series C Financing to Advance ATTOBODY-based Programs through Clinical Proof of Concept
Series C round led by Deep Track Capital with participation from additional new and existing investors; financing will fund early-to-mid-stage clinical studies for ATTO-1310 in chronic pruritus and ATTO-3712 in atopic dermatitis, and multiple earlier-stage multi-specific programs.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
0 selected
Generating previews...